SAN FRANCISCO: SAN FRANCISCO, July 29, 2021 /PRNewswire/ — Insurance companies are pushing ophthalmologists to use new biosimilar drugs as alternatives to Avastin that have never been tested in the eye, essentially making patients who depend on this c… […]
Ostensibly aiming to piggyback off the success of Royalty Pharma and CEO Pablo Legorreta’s IPO in June 2020, another royalty-gobbling company is nearly set to do the Nasdaq shuffle. Pablo Legorreta Healthcare Royalty, a Stamford, CT-based company found… […]
FREMONT, Calif. and WALTHAM, Mass.: FREMONT, Calif. and WALTHAM, Mass., July 29, 2021 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class me… […]
The FDA is sounding the alarm over its accelerated approval pathway as backlash continues over the recent nod in favor of Biogen’s Alzheimer’s drug Aduhelm, and an ODAC meeting on six such approvals that could potentially be pulled from the market — tw… […]
The process, which also facilitates name changes for religious, marital and other reasons, allows researchers of all genders to own their academic work by updating their names on previous publications. […]
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based … […]
LAS VEGAS: LAS VEGAS, July 29, 2021 /PRNewswire/ — DelveInsight’s Crohn’s Disease (CD) Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Crohn’s Disease market share of the individual therapies, current an… […]
DUBLIN: DUBLIN, July 29, 2021 /PRNewswire/ — The "Drug Delivery Systems (DDS) Global Market – Forecast To 2027" report has been added to ResearchAndMarkets.com’s offering. Global drug delivery systems market is expected to reach $158,006.4 m… […]
The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific antibody designed for the eye. Roche announced late Wednesday that its application for faricimab has been ac… […]
CAMBRIDGE, Mass. & MENLO PARK, Calif.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceu… […]
Copyright © 2021 Biotech Networks, LLC
